A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses. (2021)
Attributed to:
The use of human monoclonal antibodies to inform and enhance influenza vaccine virus selection.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-020-20654-7
PubMed Identifier: 33483491
Publication URI: http://europepmc.org/abstract/MED/33483491
Type: Journal Article/Review
Volume: 12
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723